Our Mission :

Promote translational research in cell, gene, and tissue therapy in the Province of Quebec while ensuring the visibility and international reach of the research conducted within the network.

Thécell :

Réseau de thérapie cellulaire, tissulaire et génique du Québec

Created in 2009, the Quebec Cellular, Tissue and Gene Therapy network (ThéCell) brings together over 140 regular researchers, as well as associate members and students. The Network aims to facilitate the clinical translation of cell, gene, and tissue therapies to make them more accessible to the population, while promoting technological platforms from Quebec universities and their partners. Funded by the Fonds de recherche du Québec (FRQ) – Health sector, ThéCell acts as a lever and catalyst by mobilizing and coordinating access to infrastructure and highly qualified personnel in this field.

ThéCell:

Objectifs

Develop collaborative research in the field of regenerative medicine and cell, gene, and tissue therapy.

Increase resources and facilities and optimize their use.

Focus research on clinical problems and promote the transfer of knowledge from bench to bedside.

ThéCell:

En chiffres

190+

Active members

Resources

Strategic groups - Research axes

Réjean Lapointe, PhD

rejean.lapointe@umontreal.ca

Deputy Director

Corinne Hoesli, Eng, PhD

Assistant Professor, Canada Research Chair in Bioprocess Engineering for Cell Therapy, Department of Chemical Engineering, McGill University

corinne.hoesli@mcgill.ca

Coordinator

Kim Santerre, PhD

kim.santerre.cemtl@ssss.gouv.qc.ca

Gaëtan Le-Bel, PhD

gaetan.le-bel.cemtl@ssss.gouv.qc.ca

Nolan Maugourd

nolan.maugourd.1@ulaval.ca

International Scientific Advisory Committee (CCSI)

This advisory committee is composed of a scientific expert for each axis of the network, an ethics expert, and the network director or co-director. The members of the advisory committee are appointed by the network director after consultation with the management committee. This committee's function is to provide advice on the main strategies and general orientations of the network, inform about international competitions related to cell and tissue therapies, ensure technological watch in the field of cell and tissue therapies, increase the international visibility of the network, and present proposals to the management committee.